nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—FMO1—Vandetanib—thyroid cancer	0.732	0.921	CbGbCtD
Cevimeline—CYP3A4—Vandetanib—thyroid cancer	0.0179	0.0226	CbGbCtD
Cevimeline—CYP2D6—Sorafenib—thyroid cancer	0.017	0.0214	CbGbCtD
Cevimeline—CYP3A4—Sorafenib—thyroid cancer	0.0108	0.0136	CbGbCtD
Cevimeline—CYP2D6—Doxorubicin—thyroid cancer	0.0103	0.013	CbGbCtD
Cevimeline—CYP3A4—Doxorubicin—thyroid cancer	0.00656	0.00825	CbGbCtD
Cevimeline—Abdominal pain—Sorafenib—thyroid cancer	0.00017	0.000826	CcSEcCtD
Cevimeline—Body temperature increased—Sorafenib—thyroid cancer	0.00017	0.000826	CcSEcCtD
Cevimeline—Renal impairment—Epirubicin—thyroid cancer	0.00017	0.000825	CcSEcCtD
Cevimeline—Dermatitis bullous—Epirubicin—thyroid cancer	0.000169	0.000822	CcSEcCtD
Cevimeline—Purpura—Epirubicin—thyroid cancer	0.000167	0.000815	CcSEcCtD
Cevimeline—Vascular purpura—Doxorubicin—thyroid cancer	0.000167	0.000812	CcSEcCtD
Cevimeline—Eczema—Doxorubicin—thyroid cancer	0.000166	0.000809	CcSEcCtD
Cevimeline—Eye pain—Doxorubicin—thyroid cancer	0.000165	0.000805	CcSEcCtD
Cevimeline—Hypoglycaemia—Epirubicin—thyroid cancer	0.000165	0.000805	CcSEcCtD
Cevimeline—Hyponatraemia—Epirubicin—thyroid cancer	0.000162	0.000789	CcSEcCtD
Cevimeline—Diplopia—Epirubicin—thyroid cancer	0.000161	0.000786	CcSEcCtD
Cevimeline—Pain in extremity—Epirubicin—thyroid cancer	0.000161	0.000786	CcSEcCtD
Cevimeline—Osteoarthritis—Epirubicin—thyroid cancer	0.000161	0.000786	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000161	0.000786	CcSEcCtD
Cevimeline—Hot flush—Doxorubicin—thyroid cancer	0.00016	0.000777	CcSEcCtD
Cevimeline—Increased appetite—Doxorubicin—thyroid cancer	0.000159	0.000774	CcSEcCtD
Cevimeline—Migraine—Epirubicin—thyroid cancer	0.000159	0.000773	CcSEcCtD
Cevimeline—Affect lability—Epirubicin—thyroid cancer	0.000159	0.000773	CcSEcCtD
Cevimeline—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000158	0.00077	CcSEcCtD
Cevimeline—Hypersensitivity—Sorafenib—thyroid cancer	0.000158	0.00077	CcSEcCtD
Cevimeline—Renal impairment—Doxorubicin—thyroid cancer	0.000157	0.000764	CcSEcCtD
Cevimeline—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000156	0.00076	CcSEcCtD
Cevimeline—Face oedema—Epirubicin—thyroid cancer	0.000156	0.000758	CcSEcCtD
Cevimeline—Purpura—Doxorubicin—thyroid cancer	0.000155	0.000754	CcSEcCtD
Cevimeline—Asthenia—Sorafenib—thyroid cancer	0.000154	0.00075	CcSEcCtD
Cevimeline—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000153	0.000745	CcSEcCtD
Cevimeline—Mood swings—Epirubicin—thyroid cancer	0.000153	0.000744	CcSEcCtD
Cevimeline—Pruritus—Sorafenib—thyroid cancer	0.000152	0.000739	CcSEcCtD
Cevimeline—Dehydration—Epirubicin—thyroid cancer	0.00015	0.000731	CcSEcCtD
Cevimeline—Hyponatraemia—Doxorubicin—thyroid cancer	0.00015	0.00073	CcSEcCtD
Cevimeline—Osteoarthritis—Doxorubicin—thyroid cancer	0.000149	0.000727	CcSEcCtD
Cevimeline—Diplopia—Doxorubicin—thyroid cancer	0.000149	0.000727	CcSEcCtD
Cevimeline—Pain in extremity—Doxorubicin—thyroid cancer	0.000149	0.000727	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000149	0.000727	CcSEcCtD
Cevimeline—Dry skin—Epirubicin—thyroid cancer	0.000148	0.00072	CcSEcCtD
Cevimeline—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000147	0.000717	CcSEcCtD
Cevimeline—Migraine—Doxorubicin—thyroid cancer	0.000147	0.000715	CcSEcCtD
Cevimeline—Affect lability—Doxorubicin—thyroid cancer	0.000147	0.000715	CcSEcCtD
Cevimeline—Hypokalaemia—Epirubicin—thyroid cancer	0.000147	0.000715	CcSEcCtD
Cevimeline—Diarrhoea—Sorafenib—thyroid cancer	0.000147	0.000715	CcSEcCtD
Cevimeline—Face oedema—Doxorubicin—thyroid cancer	0.000144	0.000702	CcSEcCtD
Cevimeline—Gastritis—Epirubicin—thyroid cancer	0.000143	0.000695	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000142	0.000693	CcSEcCtD
Cevimeline—Muscular weakness—Epirubicin—thyroid cancer	0.000142	0.000693	CcSEcCtD
Cevimeline—Dizziness—Sorafenib—thyroid cancer	0.000142	0.000691	CcSEcCtD
Cevimeline—Mood swings—Doxorubicin—thyroid cancer	0.000141	0.000689	CcSEcCtD
Cevimeline—Abdominal distension—Epirubicin—thyroid cancer	0.00014	0.000683	CcSEcCtD
Cevimeline—Asthma—Epirubicin—thyroid cancer	0.000139	0.000679	CcSEcCtD
Cevimeline—Dysphagia—Epirubicin—thyroid cancer	0.000139	0.000679	CcSEcCtD
Cevimeline—Dehydration—Doxorubicin—thyroid cancer	0.000139	0.000676	CcSEcCtD
Cevimeline—Eosinophilia—Epirubicin—thyroid cancer	0.000138	0.000672	CcSEcCtD
Cevimeline—Dry skin—Doxorubicin—thyroid cancer	0.000137	0.000666	CcSEcCtD
Cevimeline—Vomiting—Sorafenib—thyroid cancer	0.000136	0.000664	CcSEcCtD
Cevimeline—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000136	0.000664	CcSEcCtD
Cevimeline—Hypokalaemia—Doxorubicin—thyroid cancer	0.000136	0.000661	CcSEcCtD
Cevimeline—Angina pectoris—Epirubicin—thyroid cancer	0.000136	0.000661	CcSEcCtD
Cevimeline—Rash—Sorafenib—thyroid cancer	0.000135	0.000659	CcSEcCtD
Cevimeline—Dermatitis—Sorafenib—thyroid cancer	0.000135	0.000658	CcSEcCtD
Cevimeline—Headache—Sorafenib—thyroid cancer	0.000134	0.000654	CcSEcCtD
Cevimeline—Bronchitis—Epirubicin—thyroid cancer	0.000134	0.000653	CcSEcCtD
Cevimeline—Gastritis—Doxorubicin—thyroid cancer	0.000132	0.000643	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000132	0.000641	CcSEcCtD
Cevimeline—Muscular weakness—Doxorubicin—thyroid cancer	0.000132	0.000641	CcSEcCtD
Cevimeline—Dysuria—Epirubicin—thyroid cancer	0.00013	0.000635	CcSEcCtD
Cevimeline—Abdominal distension—Doxorubicin—thyroid cancer	0.00013	0.000632	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00013	0.000631	CcSEcCtD
Cevimeline—Asthma—Doxorubicin—thyroid cancer	0.000129	0.000628	CcSEcCtD
Cevimeline—Dysphagia—Doxorubicin—thyroid cancer	0.000129	0.000628	CcSEcCtD
Cevimeline—Pollakiuria—Epirubicin—thyroid cancer	0.000129	0.000627	CcSEcCtD
Cevimeline—Eosinophilia—Doxorubicin—thyroid cancer	0.000128	0.000622	CcSEcCtD
Cevimeline—Nausea—Sorafenib—thyroid cancer	0.000127	0.000621	CcSEcCtD
Cevimeline—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000127	0.00062	CcSEcCtD
Cevimeline—Weight increased—Epirubicin—thyroid cancer	0.000127	0.000618	CcSEcCtD
Cevimeline—Weight decreased—Epirubicin—thyroid cancer	0.000126	0.000614	CcSEcCtD
Cevimeline—Hyperglycaemia—Epirubicin—thyroid cancer	0.000126	0.000612	CcSEcCtD
Cevimeline—Angina pectoris—Doxorubicin—thyroid cancer	0.000126	0.000612	CcSEcCtD
Cevimeline—Pneumonia—Epirubicin—thyroid cancer	0.000125	0.000609	CcSEcCtD
Cevimeline—Bronchitis—Doxorubicin—thyroid cancer	0.000124	0.000604	CcSEcCtD
Cevimeline—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000122	0.000593	CcSEcCtD
Cevimeline—Stomatitis—Epirubicin—thyroid cancer	0.000121	0.00059	CcSEcCtD
Cevimeline—Conjunctivitis—Epirubicin—thyroid cancer	0.000121	0.000588	CcSEcCtD
Cevimeline—Urinary tract infection—Epirubicin—thyroid cancer	0.000121	0.000588	CcSEcCtD
Cevimeline—Dysuria—Doxorubicin—thyroid cancer	0.000121	0.000587	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00012	0.000584	CcSEcCtD
Cevimeline—Pollakiuria—Doxorubicin—thyroid cancer	0.000119	0.00058	CcSEcCtD
Cevimeline—Haematuria—Epirubicin—thyroid cancer	0.000119	0.000577	CcSEcCtD
Cevimeline—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000118	0.000573	CcSEcCtD
Cevimeline—Weight increased—Doxorubicin—thyroid cancer	0.000117	0.000572	CcSEcCtD
Cevimeline—Epistaxis—Epirubicin—thyroid cancer	0.000117	0.000571	CcSEcCtD
Cevimeline—Weight decreased—Doxorubicin—thyroid cancer	0.000117	0.000568	CcSEcCtD
Cevimeline—Sinusitis—Epirubicin—thyroid cancer	0.000117	0.000568	CcSEcCtD
Cevimeline—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000116	0.000567	CcSEcCtD
Cevimeline—Agranulocytosis—Epirubicin—thyroid cancer	0.000116	0.000565	CcSEcCtD
Cevimeline—Pneumonia—Doxorubicin—thyroid cancer	0.000116	0.000563	CcSEcCtD
Cevimeline—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000113	0.000549	CcSEcCtD
Cevimeline—Haemoglobin—Epirubicin—thyroid cancer	0.000112	0.000546	CcSEcCtD
Cevimeline—Stomatitis—Doxorubicin—thyroid cancer	0.000112	0.000546	CcSEcCtD
Cevimeline—Rhinitis—Epirubicin—thyroid cancer	0.000112	0.000545	CcSEcCtD
Cevimeline—Conjunctivitis—Doxorubicin—thyroid cancer	0.000112	0.000544	CcSEcCtD
Cevimeline—Urinary tract infection—Doxorubicin—thyroid cancer	0.000112	0.000544	CcSEcCtD
Cevimeline—Haemorrhage—Epirubicin—thyroid cancer	0.000112	0.000543	CcSEcCtD
Cevimeline—Hypoaesthesia—Epirubicin—thyroid cancer	0.000111	0.000541	CcSEcCtD
Cevimeline—Pharyngitis—Epirubicin—thyroid cancer	0.000111	0.000539	CcSEcCtD
Cevimeline—Oedema peripheral—Epirubicin—thyroid cancer	0.00011	0.000535	CcSEcCtD
Cevimeline—Haematuria—Doxorubicin—thyroid cancer	0.00011	0.000534	CcSEcCtD
Cevimeline—Urethral disorder—Epirubicin—thyroid cancer	0.000109	0.000533	CcSEcCtD
Cevimeline—Epistaxis—Doxorubicin—thyroid cancer	0.000109	0.000528	CcSEcCtD
Cevimeline—Sinusitis—Doxorubicin—thyroid cancer	0.000108	0.000525	CcSEcCtD
Cevimeline—Visual impairment—Epirubicin—thyroid cancer	0.000108	0.000524	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—thyroid cancer	0.000107	0.000523	CcSEcCtD
Cevimeline—Eye disorder—Epirubicin—thyroid cancer	0.000104	0.000508	CcSEcCtD
Cevimeline—Tinnitus—Epirubicin—thyroid cancer	0.000104	0.000507	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—thyroid cancer	0.000104	0.000505	CcSEcCtD
Cevimeline—Flushing—Epirubicin—thyroid cancer	0.000104	0.000504	CcSEcCtD
Cevimeline—Cardiac disorder—Epirubicin—thyroid cancer	0.000104	0.000504	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—thyroid cancer	0.000104	0.000504	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—thyroid cancer	0.000103	0.000503	CcSEcCtD
Cevimeline—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000103	0.0005	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—thyroid cancer	0.000103	0.000499	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—thyroid cancer	0.000102	0.000495	CcSEcCtD
Cevimeline—Angiopathy—Epirubicin—thyroid cancer	0.000101	0.000493	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—thyroid cancer	0.000101	0.000493	CcSEcCtD
Cevimeline—Chills—Epirubicin—thyroid cancer	0.0001	0.000488	CcSEcCtD
Cevimeline—Arrhythmia—Epirubicin—thyroid cancer	9.97e-05	0.000485	CcSEcCtD
Cevimeline—Visual impairment—Doxorubicin—thyroid cancer	9.95e-05	0.000485	CcSEcCtD
Cevimeline—Alopecia—Epirubicin—thyroid cancer	9.87e-05	0.00048	CcSEcCtD
Cevimeline—Malnutrition—Epirubicin—thyroid cancer	9.72e-05	0.000473	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—thyroid cancer	9.65e-05	0.00047	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—thyroid cancer	9.63e-05	0.000469	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—thyroid cancer	9.59e-05	0.000467	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—thyroid cancer	9.59e-05	0.000467	CcSEcCtD
Cevimeline—Flatulence—Epirubicin—thyroid cancer	9.58e-05	0.000466	CcSEcCtD
Cevimeline—Dysgeusia—Epirubicin—thyroid cancer	9.52e-05	0.000463	CcSEcCtD
Cevimeline—Back pain—Epirubicin—thyroid cancer	9.4e-05	0.000458	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—thyroid cancer	9.37e-05	0.000456	CcSEcCtD
Cevimeline—Muscle spasms—Epirubicin—thyroid cancer	9.34e-05	0.000455	CcSEcCtD
Cevimeline—Chills—Doxorubicin—thyroid cancer	9.27e-05	0.000451	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—thyroid cancer	9.23e-05	0.000449	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—thyroid cancer	9.13e-05	0.000444	CcSEcCtD
Cevimeline—Ill-defined disorder—Epirubicin—thyroid cancer	9.02e-05	0.000439	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—thyroid cancer	8.99e-05	0.000438	CcSEcCtD
Cevimeline—Anaemia—Epirubicin—thyroid cancer	8.98e-05	0.000437	CcSEcCtD
Cevimeline—Agitation—Epirubicin—thyroid cancer	8.93e-05	0.000435	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—thyroid cancer	8.86e-05	0.000431	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—thyroid cancer	8.81e-05	0.000429	CcSEcCtD
Cevimeline—Malaise—Epirubicin—thyroid cancer	8.76e-05	0.000427	CcSEcCtD
Cevimeline—Vertigo—Epirubicin—thyroid cancer	8.73e-05	0.000425	CcSEcCtD
Cevimeline—Syncope—Epirubicin—thyroid cancer	8.72e-05	0.000424	CcSEcCtD
Cevimeline—Leukopenia—Epirubicin—thyroid cancer	8.7e-05	0.000423	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—thyroid cancer	8.7e-05	0.000423	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—thyroid cancer	8.65e-05	0.000421	CcSEcCtD
Cevimeline—Palpitations—Epirubicin—thyroid cancer	8.59e-05	0.000418	CcSEcCtD
Cevimeline—Loss of consciousness—Epirubicin—thyroid cancer	8.54e-05	0.000416	CcSEcCtD
Cevimeline—Cough—Epirubicin—thyroid cancer	8.48e-05	0.000413	CcSEcCtD
Cevimeline—Convulsion—Epirubicin—thyroid cancer	8.42e-05	0.00041	CcSEcCtD
Cevimeline—Hypertension—Epirubicin—thyroid cancer	8.39e-05	0.000408	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—thyroid cancer	8.34e-05	0.000406	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—thyroid cancer	8.31e-05	0.000405	CcSEcCtD
Cevimeline—Arthralgia—Epirubicin—thyroid cancer	8.27e-05	0.000403	CcSEcCtD
Cevimeline—Myalgia—Epirubicin—thyroid cancer	8.27e-05	0.000403	CcSEcCtD
Cevimeline—Chest pain—Epirubicin—thyroid cancer	8.27e-05	0.000403	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—thyroid cancer	8.26e-05	0.000402	CcSEcCtD
Cevimeline—Anxiety—Epirubicin—thyroid cancer	8.25e-05	0.000401	CcSEcCtD
Cevimeline—Discomfort—Epirubicin—thyroid cancer	8.17e-05	0.000398	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—thyroid cancer	8.11e-05	0.000395	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—thyroid cancer	8.08e-05	0.000393	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—thyroid cancer	8.06e-05	0.000393	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—thyroid cancer	8.05e-05	0.000392	CcSEcCtD
Cevimeline—Confusional state—Epirubicin—thyroid cancer	8e-05	0.000389	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—thyroid cancer	7.95e-05	0.000387	CcSEcCtD
Cevimeline—Oedema—Epirubicin—thyroid cancer	7.93e-05	0.000386	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—thyroid cancer	7.9e-05	0.000385	CcSEcCtD
Cevimeline—Infection—Epirubicin—thyroid cancer	7.88e-05	0.000384	CcSEcCtD
Cevimeline—Cough—Doxorubicin—thyroid cancer	7.85e-05	0.000382	CcSEcCtD
Cevimeline—Shock—Epirubicin—thyroid cancer	7.8e-05	0.00038	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—thyroid cancer	7.79e-05	0.000379	CcSEcCtD
Cevimeline—Nervous system disorder—Epirubicin—thyroid cancer	7.78e-05	0.000379	CcSEcCtD
Cevimeline—Thrombocytopenia—Epirubicin—thyroid cancer	7.77e-05	0.000378	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—thyroid cancer	7.76e-05	0.000378	CcSEcCtD
Cevimeline—Tachycardia—Epirubicin—thyroid cancer	7.74e-05	0.000377	CcSEcCtD
Cevimeline—Skin disorder—Epirubicin—thyroid cancer	7.7e-05	0.000375	CcSEcCtD
Cevimeline—Hyperhidrosis—Epirubicin—thyroid cancer	7.67e-05	0.000373	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—thyroid cancer	7.66e-05	0.000373	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—thyroid cancer	7.66e-05	0.000373	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—thyroid cancer	7.66e-05	0.000373	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—thyroid cancer	7.63e-05	0.000371	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—thyroid cancer	7.56e-05	0.000368	CcSEcCtD
Cevimeline—Anorexia—Epirubicin—thyroid cancer	7.56e-05	0.000368	CcSEcCtD
Cevimeline—Hypotension—Epirubicin—thyroid cancer	7.41e-05	0.000361	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—thyroid cancer	7.4e-05	0.00036	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—thyroid cancer	7.34e-05	0.000357	CcSEcCtD
Cevimeline—Infection—Doxorubicin—thyroid cancer	7.29e-05	0.000355	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.23e-05	0.000352	CcSEcCtD
Cevimeline—Shock—Doxorubicin—thyroid cancer	7.22e-05	0.000351	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—thyroid cancer	7.2e-05	0.00035	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—thyroid cancer	7.19e-05	0.00035	CcSEcCtD
Cevimeline—Insomnia—Epirubicin—thyroid cancer	7.17e-05	0.000349	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—thyroid cancer	7.16e-05	0.000349	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—thyroid cancer	7.13e-05	0.000347	CcSEcCtD
Cevimeline—Paraesthesia—Epirubicin—thyroid cancer	7.12e-05	0.000347	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—thyroid cancer	7.09e-05	0.000345	CcSEcCtD
Cevimeline—Dyspnoea—Epirubicin—thyroid cancer	7.07e-05	0.000344	CcSEcCtD
Cevimeline—Somnolence—Epirubicin—thyroid cancer	7.05e-05	0.000343	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—thyroid cancer	7e-05	0.000341	CcSEcCtD
Cevimeline—Dyspepsia—Epirubicin—thyroid cancer	6.98e-05	0.00034	CcSEcCtD
Cevimeline—Decreased appetite—Epirubicin—thyroid cancer	6.89e-05	0.000336	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—thyroid cancer	6.86e-05	0.000334	CcSEcCtD
Cevimeline—Fatigue—Epirubicin—thyroid cancer	6.84e-05	0.000333	CcSEcCtD
Cevimeline—Pain—Epirubicin—thyroid cancer	6.78e-05	0.00033	CcSEcCtD
Cevimeline—Constipation—Epirubicin—thyroid cancer	6.78e-05	0.00033	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.69e-05	0.000325	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—thyroid cancer	6.64e-05	0.000323	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—thyroid cancer	6.59e-05	0.000321	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—thyroid cancer	6.54e-05	0.000318	CcSEcCtD
Cevimeline—Feeling abnormal—Epirubicin—thyroid cancer	6.54e-05	0.000318	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—thyroid cancer	6.52e-05	0.000318	CcSEcCtD
Cevimeline—Gastrointestinal pain—Epirubicin—thyroid cancer	6.49e-05	0.000316	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—thyroid cancer	6.46e-05	0.000314	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—thyroid cancer	6.38e-05	0.000311	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—thyroid cancer	6.33e-05	0.000308	CcSEcCtD
Cevimeline—Urticaria—Epirubicin—thyroid cancer	6.3e-05	0.000307	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—thyroid cancer	6.28e-05	0.000305	CcSEcCtD
Cevimeline—Pain—Doxorubicin—thyroid cancer	6.28e-05	0.000305	CcSEcCtD
Cevimeline—Body temperature increased—Epirubicin—thyroid cancer	6.27e-05	0.000305	CcSEcCtD
Cevimeline—Abdominal pain—Epirubicin—thyroid cancer	6.27e-05	0.000305	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—thyroid cancer	6.05e-05	0.000294	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—thyroid cancer	6e-05	0.000292	CcSEcCtD
Cevimeline—Hypersensitivity—Epirubicin—thyroid cancer	5.84e-05	0.000284	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—thyroid cancer	5.83e-05	0.000284	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—thyroid cancer	5.8e-05	0.000282	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—thyroid cancer	5.8e-05	0.000282	CcSEcCtD
Cevimeline—Asthenia—Epirubicin—thyroid cancer	5.69e-05	0.000277	CcSEcCtD
Cevimeline—Pruritus—Epirubicin—thyroid cancer	5.61e-05	0.000273	CcSEcCtD
Cevimeline—Diarrhoea—Epirubicin—thyroid cancer	5.43e-05	0.000264	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—thyroid cancer	5.41e-05	0.000263	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—thyroid cancer	5.27e-05	0.000256	CcSEcCtD
Cevimeline—Dizziness—Epirubicin—thyroid cancer	5.24e-05	0.000255	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—thyroid cancer	5.19e-05	0.000253	CcSEcCtD
Cevimeline—Vomiting—Epirubicin—thyroid cancer	5.04e-05	0.000245	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—thyroid cancer	5.02e-05	0.000244	CcSEcCtD
Cevimeline—Rash—Epirubicin—thyroid cancer	5e-05	0.000243	CcSEcCtD
Cevimeline—Dermatitis—Epirubicin—thyroid cancer	5e-05	0.000243	CcSEcCtD
Cevimeline—Headache—Epirubicin—thyroid cancer	4.97e-05	0.000242	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—thyroid cancer	4.85e-05	0.000236	CcSEcCtD
Cevimeline—Nausea—Epirubicin—thyroid cancer	4.71e-05	0.000229	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—thyroid cancer	4.67e-05	0.000227	CcSEcCtD
Cevimeline—Rash—Doxorubicin—thyroid cancer	4.63e-05	0.000225	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—thyroid cancer	4.62e-05	0.000225	CcSEcCtD
Cevimeline—Headache—Doxorubicin—thyroid cancer	4.6e-05	0.000224	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—thyroid cancer	4.36e-05	0.000212	CcSEcCtD
Cevimeline—FMO1—trachea—thyroid cancer	4.01e-05	0.177	CbGeAlD
Cevimeline—FMO1—thyroid gland—thyroid cancer	3.17e-05	0.14	CbGeAlD
Cevimeline—FMO1—head—thyroid cancer	2.82e-05	0.124	CbGeAlD
Cevimeline—CHRM1—saliva-secreting gland—thyroid cancer	2.39e-05	0.105	CbGeAlD
Cevimeline—CHRM3—saliva-secreting gland—thyroid cancer	2.14e-05	0.0941	CbGeAlD
Cevimeline—FMO1—lymph node—thyroid cancer	1.97e-05	0.0868	CbGeAlD
Cevimeline—CHRM1—trachea—thyroid cancer	1.84e-05	0.0811	CbGeAlD
Cevimeline—CHRM3—thyroid gland—thyroid cancer	1.3e-05	0.0574	CbGeAlD
Cevimeline—CHRM1—head—thyroid cancer	1.29e-05	0.0569	CbGeAlD
Cevimeline—CHRM3—head—thyroid cancer	1.16e-05	0.0509	CbGeAlD
Cevimeline—CYP2D6—head—thyroid cancer	6.26e-06	0.0275	CbGeAlD
